Novel hybrid 1,2,4- and 1,2,3-triazoles targeting mycobacterium tuberculosis enoyl acyl carrier protein reductase (inha): design, synthesis, and molecular docking

HIGHLIGHTS

• who: Maged A. El Sawy and collaborators from the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Pharos University, Alexandria, Egypt have published the Article: Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking, in the Journal: (JOURNAL) of 24/04/2022
• how: The designed compounds were tested in vitro against the enzyme. The newly synthesized A series of novel 123-triazoles tethered to a 124-triazol motif 7(a-f) were synthecompounds were tested in_vitro against theamycobacterium tuberculosis InhA in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.